全球霍乱疫苗市场 – 行业趋势及 2030 年预测

霍乱疫苗市场分析及规模

据估计，全球每年有 130 万至 400 万例霍乱病例，导致 21,000 至 1,43,000 人死亡。在这方面，霍乱疫苗得到了广泛使用。几家主要的市场参与者正在生产高效且具有成本效益的霍乱疫苗，预计这将促进市场的增长。由于霍乱是一种众所周知的公共卫生威胁，各国政府正在投入大量资金，为最弱势的人群提供改善的水和卫生设施，由于卫生条件差，这些人仍然受到该疾病的严重影响。

Data Bridge Market Research 分析了 2023-2030 年预测期内霍乱疫苗市场的增长率。在上述预测期内，霍乱疫苗市场的预期复合年增长率约为 9.1%。2022 年市场价值为 9522 万美元，到 2030 年将增长至 1.9113 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

霍乱疫苗市场范围和细分

市场定义

Cholera is a type of infectious disease caused by ingesting food and water contaminated with the bacterium named as vibrio cholera. The infection has short incubation period from few hours to five days. Cholera can be fatal sometimes. The cholera vaccine inserts a small dose of live cholera bacteria in the body which helps to develop immunity against the disease. It can be given orally, intradermally or intramuscularly in the body.

Cholera Vaccines Market Dynamics

Drivers

• Rising Incidence of Cholera Cases

As per the WHO statistics, an estimated 1.3 to 4.0 million cases of cholera are witnessed every year. The disease impacts any age group starting from children as well as adults and can result in death, if left untreated. Cholera is associated to the decreased availability of clean water and sanitation facilities. In this regard, the WHO Global Task Force on Cholera Control (GTFCC) a program aimed at controlling the spread of cholera by 2030, was launched to decrease the mortality risk related with the disease by 90% in cholera prone areas such as Asia and Africa. This is contributing to the increased demand for cholera vaccines worldwide.

Opportunities

• Rising Demand of Dukoral

Dukoral is projected to hold a major share of the market. Dukoral is the only oral (drinkable) vaccine available in the market, that provides protection against diseases such as cholera and diarrhoea caused by Enterotoxigenic E. coli (ETEC) which is contributes somewhat to increasing the market growth. Additionally, Dukoral can be given to adults and children 2 years of age and older. Besides this, the increasing population in the cholera endemic region as well as the individuals travelling to the said region are also estimated to boost the segment growth in the upcoming years.

• Increasing Awareness About the Disease

The growing concerns associated with cholera outbreaks and the advent of new strains which might be of greater severity are leading to a rise in R&D activities by both government and private bodies. The increasing awareness related to the vaccines and the increased availability of oral vaccines in the region are also projected to boost the market growth in the coming years. The wide adoption of water, sanitation, and hygiene practices has proven to be effective in protecting the population, combined with the use of oral cholera vaccines (OCVs).

 Restraints/Challenges

• Longer time required for production of vaccine

The time required to complete a batch of vaccine is pretty long and thus can work as a restrict to the market. The time varies slightly as a function of production scale and varies from 41 h in case of the 1 L scale process to 48.2 h in case of the 30 L scale process. Thus, it restricts the market growth.

• High Cost For Drug Development

The current treatment options for cholera vaccines are limited to antibiotics, and numerous pharmaceutical companies are presently focusing on developing non-antibiotic alternatives. Developing a new class of drugs will offer many growth opportunities for key players, but it will also essentially require major investments in R&D activities of novel therapies. The considerably high investment requirements may act as an obstacle to market growth.  

This cholera vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cholera vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cholera Vaccines Market Scope

The cholera vaccines market is segmented on the basis of type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Dukoral
• Shanchol
• Euvichol

Route of Administration

• Oral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cholera Vaccines Market Regional Analysis/Insights

The cholera vaccines market is analyzed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the cholera vaccines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for cholera vaccines market throughout the forecasted period due to the presence of key commodity production, high research and development and healthcare expenditure and trained practitioners.  

Asia-Pacific dominates the market due to an increased prevalence of chronic diseases and poor sanitation conditions.

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球霍乱疫苗市场份额分析

霍乱疫苗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对霍乱疫苗市场的关注有关。

霍乱疫苗市场的主要参与者包括：

• Valneva SE.（法国）
• 新兴市场（美国）
• 安斯泰来制药株式会社（日本）
• 赛诺菲（法国）
• EUBIOLOGICS CO., LTD (韩国)
• 强生服务公司 (印度)
• Celldex Therapeutics。（美国）
• 默克公司（美国）
• 葛兰素史克公司 (英国)

SKU-56819